FindTrial
Sign In

An open label single arm clinical study of ushiradi vati in emesis gravidarum(garbhini chardi)

An opened label single armed clinical study of Ushiradi Vati in Garbhini Chardi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038162
Enrollment
45
Registered
2021-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O99- Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Ushiradi Vati: Dose- 1 tablet four times a day Route of Administration- Oral Duration of therapy- 56 days Control Intervention1: NIL: NIL

Sponsors

Anurag Kisan Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All diagnosed Garbhini chardi patients with GA 6th week to 14th weeks having single live intrauterine pregnancy irrespective of parity & religion . 2.All diagnosed Garbhini chardi patients having age group 19-35 years.

Exclusion criteria

Exclusion criteria: 1. patient with multiple pregnancy and vesicular mole. 2. garbhini with complaints of Krumij chardi and Ajirnaj chardi . 3.pregnant women with vomitting due to other systemic diseases peptic ulcer, liver & kidney diseases, hypertension etc. 4.k/c/o diabetes mellitus / gestational diabetes mellitus

Design outcomes

Primary

MeasureTime frame
primary outcome- 1.To study the effect of Ushiradi vati in Garbhini Chardi(emesis gravidarum)Timepoint: for each patient treatment duration 56 days clinical study within 14 months(all 45 patient)—

Secondary

MeasureTime frame
1.Garbhini chardi will be studied in detail 2.to study etiopathogenesis of garbhini chardi . 3.adverse effects of Ushiradi vati if any will be observed during study .Timepoint: 14 months—

Countries

India

Contacts

Public ContactDrKalpana Bajrang Ayare

Sumatibhai Shah Ayurved Mahavidyalay

drkalpanaayare@gmail.com9423295630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026